CA
PFE icon

Commerzbank Aktiengesellschaft’s Pfizer PFE Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,000
Closed -$71K – 73
2022
Q1 		$71K Buy
19,000
+9,000
+90% +$467K ﹤0.01% 67
2021
Q4 		$42K Buy
+10,000
New +$495K ﹤0.01% 69
2021
Q3 		– Sell
-115,800
Closed -$113K – 78
2021
Q2 		$113K Buy
115,800
+92,800
+403% +$3.61M 0.01% 68
2021
Q1 		$38K Buy
23,000
+9,000
+64% +$320K ﹤0.01% 76
2020
Q4 		$44K Sell
14,000
-756
-5% -$27.7K ﹤0.01% 83
2020
Q3 		$83K Buy
+14,756
New +$517K 0.01% 77
2020
Q1 		– Sell
-12,648
Closed -$13K – 651
2019
Q4 		$13K Buy
+12,648
New +$451K ﹤0.01% 693
2019
Q3 		– Sell
-609,950
Closed -$1.35M – 985
2019
Q2 		$1.35M Buy
609,950
+430,454
+240% +$17.1M 0.01% 544
2019
Q1 		$796K Sell
179,496
-203,422
-53% -$8.15M 0.01% 550
2018
Q4 		$821K Buy
382,918
+188,666
+97% +$7.83M 0.01% 577
2018
Q3 		$22K Hold
194,252
– – ﹤0.01% 976
2018
Q2 		$276K Buy
+194,252
New +$6.64M ﹤0.01% 786
2018
Q1 		– Sell
-158,100
Closed -$11K – 1010
2017
Q4 		$11K Buy
+158,100
New +$5.39M ﹤0.01% 920
2016
Q1 		– Sell
-105,400
Closed -$3.23M – 1119
2015
Q4 		$3.23M Buy
+105,400
New +$3.32M 0.02% 389
2015
Q1 		– Sell
-131,750
Closed -$3.89M – 1211
2014
Q4 		$3.89M Buy
131,750
+52,700
+67% +$1.51M 0.02% 474
2014
Q3 		$2.22M Hold
79,050
– – 0.01% 713
2014
Q2 		$2.23M Hold
79,050
– – 0.01% 687
2014
Q1 		$2.41M Sell
79,050
-527
-0.7% -$15.7K 0.01% 661
2013
Q4 		$2.29M Buy
79,577
+527
+0.7% +$15.3K 0.01% 708
2013
Q3 		$2.15M Sell
79,050
-529,108
-87% -$14.4M 0.01% 709
2013
Q2 		$16.2M Buy
+608,158
New +$16.8M 0.07% 219

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Commerzbank Aktiengesellschaft's PFE Position: Q2 2026 in Review

Commerzbank Aktiengesellschaft increased its Pfizer (PFE) stake by 0.08% in Q2 2026, buying an estimated $9.55K and bringing the position to 444,778 shares worth $10.7M. The position accounts for 0.21% of the portfolio, ranked #57.

Commerzbank Aktiengesellschaft first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $519M in Q2 2013. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Commerzbank Aktiengesellschaft held 444,778 shares of Pfizer worth $10.7M as of Q2 2026.
  • Commerzbank Aktiengesellschaft bought 365 Pfizer shares in Q2 2026, an estimated $9.55K.
  • Pfizer made up 0.21% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #57 holding.
  • Commerzbank Aktiengesellschaft first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Commerzbank Aktiengesellschaft's Pfizer position peaked at $519M in Q2 2013.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.